BERENICE: Further Evidence of Heart Safety of Dual HER2 Blockade ...Middle East

News by : (Medscape) -
Final results were presented at ESMO Breast Cancer 2021 on dual HER2 blockade with pertuzumab and trastuzumab on top of anthracycline-based neoadjuvant chemotherapy for early-stage breast cancer. Medscape Medical News

Hence then, the article about berenice further evidence of heart safety of dual her2 blockade was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BERENICE: Further Evidence of Heart Safety of Dual HER2 Blockade )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار